Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Opin Virol. 2013 Jun;3(3):238-44. doi: 10.1016/j.coviro.2013.05.012. Epub 2013 Jun 13.

Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update.

Author information

1
Lineberger Comprehensive Cancer Center and Department of Microbiology & Immunology, Program in Global Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States.

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV) is the etiological agent of several human malignancies. The virus is able to modulate pro-proliferative pathways to its advantage, while simultaneously inhibiting pro-apoptotic signaling pathways. These functions are carried out by multiple viral proteins acting in concert. The overall outcome is the survival and proliferation of the infected cell. Additionally, the virus also modulates innate immune pathways to allow for prolonged survival of the infected cell following primary infection, and during viral latency. Here we review the latest advances in our knowledge of KSHV pathogenesis.

PMID:
23769237
PMCID:
PMC3716290
DOI:
10.1016/j.coviro.2013.05.012
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center